Cyberark Software Ltd. (CYBR) 58.02 $CYBR Palo Alto

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cyberark Software Ltd. (CYBR) 58.02 $CYBR

Palo Alto Networks Price Targets Hiked On Q2 Beat
at Investor's Business Daily - Tue Mar 03, 11:25AM CST
Palo Alto Networks (PANW) received several price target increases Tuesday following its fiscal Q2 beat and solid outlook late Monday, as more customers seek its products and services to fend off more sophisticated cyberthreats. "For the third...
FEYE: 45.07 (+0.25), CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92), SYMC: 24.76 (-0.50)

These 4 Stocks Have World-Beating EPS Estimates
at Investor's Business Daily - Mon Mar 02, 8:20PM CST
Today's Screen of the Day is International Leaders, and we're taking a look at the top global stocks with world-beating EPS growth estimates. Here's a breakdown of the top four: CyberArk Software (CYBR) sits at the top of the list and leads the...
CYBR: 58.02 (+0.28), NXPI: 98.73 (-0.83), FSL: 40.50 (+0.14), MLNX: 46.30 (-0.82), AAPL: 129.36 (+0.27), PANW: 148.90 (+2.92), SIMO: 27.72 (-0.24), AVGO: 128.22 (-0.80)

Palo Alto Networks Earnings Soar On Security Threats
at Investor's Business Daily - Mon Mar 02, 3:26PM CST
Palo Alto Networks (PANW) late Monday posted fiscal Q2 earnings and revenue growth that beat Wall Street targets, and its guidance for the current quarter also edged views. For the quarter ended Jan. 31, the network security vendor reported earnings...
FEYE: 45.07 (+0.25), CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92), CHKP: 83.22 (-1.13)

Palo Alto Networks Q2 Seen Maintaining Momentum
at Investor's Business Daily - Sat Feb 28, 7:02AM CST
Palo Alto Networks (PANW) is expected to post double-digit growth in earnings and revenue when it reports fiscal Q2 results after the market close Monday. Analysts polled by Thomson Reuters expect Palo Alto Networks to report earnings per share...
CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92), CHKP: 83.22 (-1.13)

CyberArk drops after announcing pre-lockup offering
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:56AM CST

CYBR: 58.02 (+0.28)

CyberArk Software - Finding Digital Intruders And Traitors Doubles Share Price In Less Than A Year
Financial Markets Wizard - Seeking Alpha - Fri Feb 27, 5:57AM CST
Humans have always had the need for security. In the earliest days of civilization, early humans would bury their valuable possessions, or hide them in caves. As time went on, skilled trades people crafted vaults and safes to store the valuables of...
CYBR: 58.02 (+0.28)

CyberArk Remains Strong; Other Israeli Stocks Lag
at Investor's Business Daily - Wed Feb 25, 5:01PM CST
Israel-based stocks were in motion Wednesday, as SodaStream International dived 9%, CyberArk was flat and Mobileye geared up to report results before Thursday's open. Israel has an annual GDP between that of Singapore and Chile yet has one of the...
RDWR: 21.99 (-0.31), CSTE: 63.61 (-1.93), CYBR: 58.02 (+0.28), MBLY: 33.81 (+0.15), SODA: 18.26 (+0.43)

Increased Earnings Estimates Seen for CyberArk Software Ltd (CYBR): Can It Move Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 7:41AM CST
CyberArk Software in the technology space is seeing solid activity on the earnings estimate revision front
CYBR: 58.02 (+0.28)

CyberArk (CYBR) Stock Rises Today Following Monday's Decline on Analyst Downgrade
at The Street - Tue Feb 24, 9:53AM CST
Shares of CyberArk (CYBR) were up in morning trading Tuesday as investors swooped in to buy the stock following its decline Monday after JPMorgan downgraded the stock to 'underweight.'
CYBR: 58.02 (+0.28)

3 ETFs Leading the Technology Sector Surge - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Feb 24, 9:00AM CST
While all the tech ETFs have given handsome returns from a year-to-date look, funds targeting some niche strategies are crushing the broader space.
NFLX: 474.71 (-5.54), AMZN: 384.61 (-1.04), HACK: 29.16 (-0.15), FEYE: 45.07 (+0.25), CYBR: 58.02 (+0.28), FB: 79.60 (-0.15), FDN: 66.31 (-0.45), ARKW: 22.14 (-0.27), TWTR: 47.71 (-0.44), AAPL: 129.36 (+0.27)

Market Is Not In A Bubble - Cramer's Mad Money (2/23/15)
SA Editor Mohit Manghnani - Seeking Alpha - Tue Feb 24, 6:40AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, February 23. With Nasdaq near all-time highs after 15 years, Cramer is listening to people talk about a new bubble forming. He said one of the good things about...
TSLA: 199.56 (+2.24), VRX: 202.61 (-0.74), CYBR: 58.02 (+0.28), AMGN: 158.56 (-1.07), INTC: 34.10 (+0.04), GOOG: 573.64 (+2.30), ORCL: 43.38 (-0.65), CELG: 118.47 (-1.84), AGEN: 4.85 (-0.03), T: 34.41 (-0.23), CTB: 38.55 (+0.03), JPM: 61.97 (+0.20), GILD: 102.79 (-1.04), HZNP: 20.97 (+0.46), GM: 37.80 (+0.19), GOOGL: 578.79 (+3.77), MSFT: 43.28 (-0.60), VZ: 49.55 (+0.08), DOW: 49.25 (-0.10), AAPL: 129.36 (+0.27), REGN: 412.50 (-5.94), CSCO: 29.54 (-0.65)

As More Cyber Threats Emerge, These Three Cyber Security Firms Bear Watching
at The Street - Tue Feb 24, 6:10AM CST
As more organizations suffer major security breaches, cyber security firms are using new technology to combat intruders.
FEYE: 45.07 (+0.25), CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92)

Genetic Technologies Remains Among Most Difficult To Borrow Names
Interactive Brokers - at Seeking Alpha - Tue Feb 24, 12:46AM CST
Genetic Technologies Limited (NASDAQ: GENE ) continues to be one of the most sought after borrows, and while liquidity remains scarce, what little supply is available to borrow is expensive. Although the price of GENE shares has come down...
GPRO: 40.30 (+0.37), TSLA: 199.56 (+2.24), CYBR: 58.02 (+0.28), MNKD: 6.16 (-0.48), GENE: 5.36 (-0.37), BLDP: 2.33 (-0.04), WPRT: 5.63 (-0.04), ATOS: 1.96 (-0.07), SGNL: 2.69 (-0.03), RIG: 16.51 (+0.03), OPK: 14.40 (-0.04), PSTR: 3.90 (-0.06), LINE: 11.67 (+0.11), ZU: 13.87 (-0.02)

3 Impressive Cyber Security Stocks to Buy on the Dip - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Feb 23, 7:41PM CST
These cyber security stocks were hit hard in Monday trading but they may still be great picks for investors.
VDSI: 23.71 (+0.37), CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92)

Jim Cramer's 'Mad Money' Recap: Calm Down, There's No Nasdaq Bubble
at The Street - Mon Feb 23, 7:24PM CST
Despite the many strides the market has made since 2000, critics are once again calling the Nasdaq overvalued and in 'bubble' territory. Cramer details why they're wrong.
TSLA: 199.56 (+2.24), BCRX: 10.06 (-0.22), VRX: 202.61 (-0.74), BX: 37.85 (-0.29), CYBR: 58.02 (+0.28), INTC: 34.10 (+0.04), EEP: 38.57 (+0.15), YHOO: 42.62 (-1.49), APO: 23.20 (+0.01), JPM: 61.97 (+0.20), KATE: 34.58 (-0.72), FTK: 16.70 (-0.03), MSFT: 43.28 (-0.60), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65), REGN: 412.50 (-5.94), XEL: 34.69 (+0.28), XEC: 110.69 (+0.84), SLXP: 156.50 (-0.38), AMGN: 158.56 (-1.07), WFC: 55.45 (-0.10), ORCL: 43.38 (-0.65), CELG: 118.47 (-1.84), ISIS: 68.66 (+1.86), ARRS: 29.62 (-0.19), GILD: 102.79 (-1.04), DOW: 49.25 (-0.10)

Apple Jumps on Car Rumors, CyberArk Tanks on Downgrade: Tech Winners & Losers
at The Street - Mon Feb 23, 4:31PM CST
Apple hits a record high as investors give a thumbs-up if it creates an electric car. CyberArk tanks on a downgrade, pushing other security vendors lower.
VDSI: 23.71 (+0.37), FEYE: 45.07 (+0.25), CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92), AAPL: 129.36 (+0.27)

CyberArk Software Stock Plunges On Downgrade
at Investor's Business Daily - Mon Feb 23, 2:00PM CST
Shares of CyberArk Software (CYBR) plunged Monday after JPMorgan downgraded the stock. CyberArk shares are still up about 70% from Feb. 9, when the cybersecurity stock began its huge recent run. Meanwhile, industry group peer Palo Alto Networks...
VDSI: 23.71 (+0.37), FEYE: 45.07 (+0.25), CYBR: 58.02 (+0.28), PANW: 148.90 (+2.92)

Why Cyberark Software Ltd Stock Plunged Today
Steve Symington, The Motley Fool - Motley Fool - Mon Feb 23, 1:47PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of CyberArk Software Ltd were down more than...
JPM: 61.97 (+0.20), CYBR: 58.02 (+0.28)

Cyber Threat Response Investing Vehicles - HACK
Peter F. Way, CFA - at Seeking Alpha - Mon Feb 23, 1:36PM CST

HACK: 29.16 (-0.15), CYBR: 58.02 (+0.28)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading